Dr. Reddy’s Laboratories Continues its Voluntary Nationwide Recall of Levetiracetam in 0.54% Sodium Chloride Injection 1

› Budget101 Discussion List Archives › Recalls › Dr. Reddy’s Laboratories Continues its Voluntary Nationwide Recall of Levetiracetam in 0.54% Sodium Chloride Injection 1

Viewing 0 reply threads
  • Author
    Posts
    • February 4, 2019 at 3:40 pm #396082
      budget

      Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that it’s wholly owned subsidiary, Dr Reddy’s Laboratories, Inc is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetram in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags to the hospital level in U.S.A.

      Read More…

      This notice provided by Budget101.com

  • Author
    Posts
Viewing 0 reply threads
  • You must be logged in to reply to this topic.

› Budget101 Discussion List Archives › Recalls › Dr. Reddy’s Laboratories Continues its Voluntary Nationwide Recall of Levetiracetam in 0.54% Sodium Chloride Injection 1